The C‐terminal tails of 4,4'‐diphenylmethane‐bis(methyl) carbamate are essential for binding to receptor for advanced glycation end products to attenuate advanced glycation end products‐induced inflammation and apoptosis responses in human umbilical vein endothelial cells